ECI, Inc. engages in the business of innovative drug discovery and its related services. It operates through the following segments: Drug Discovery Business, Drug Discovery Tool Supply and Health Food. The Drug Discovery Business segment engages in the research and development of drug discovery seeds and core technology. The Drug Discovery Tool Supply segment develops and sells laboratory equipment. The Health Food segment sells health food ingredients and agricultural supplements in bulk. The company was founded by Shiro Kanegasaki in June 1999 and is headquartered in Tachikawa, Japan.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Hirata Corp. engages in the manufacture and sale of manufacturing line systems, industrial robots, and logistics equipment. It operates through the following divisions: Automotive-Related Production Equipment, Semiconductor-Related Equipment, and Home Appliance and Other Production Equipment. The Automotive-Related Production division manufactures engines, transmission systems, and automotive components such as computerized control systems, sensors, air compressors, and brakes. The Semiconductor-Related Equipment division deals with the manufacture and sale of silicon wafer transfer equipment, flat panel display (FPD) production equipment, and vapor deposition equipment. The Home Appliance and Other Production Equipment division markets household electric appliances such as vacuum cleaners, refrigerators, logistic-related equipment such as stockers, conveyors, and tire-related production equipment. The company was founded on December 29, 1951 and is headquartered in Kumamoto, Japan.

Dompe Farmaceutici SpA operates as a biopharmaceutical company. It develops pharmaceutical and biotechnological drugs. The firm provides updating and scientific assistance services to doctors of general medicine, paediatrics, pneumology, otology, orthopaedics, rheumatology, physiatrist, odontology, accident and emergency and first aid stations. The company was founded by Franco Domp�� in 1940 and is headquartered in Milan, Italy.

The University of Iowa Research Foundation (UIRF) - a 501C3 corporation - commercializes University of Iowa developed technologies and inventions through licensing and new venture formation, and manages the subsequent revenue stream.

Neurogen Corporation is a drug development company historically focusing on small-molecule drugs to improve the lives of patients suffering from psychiatric and neurological disorders with significant unmet medical need. Neurogen has conducted its drug development independently and, when advantageous, collaborated with world-class pharmaceutical companies to access additional resources and expertise.

Dompé SpA provides services of updating and scientific assistance to doctors. It offers information on therapeutic areas including physiatrics, cystic fibrosis, geriatrics, infectious diseases, internal, sleep and sports medicine, odontology, orthopedics and traumatology, otorhinolaryngology, pediatrics, pneumology, and emergency and drugs. The company was founded by Sergio Dompé in 1993 and is headquartered in L'Aquila, Italy.

Korea Institute of Industrial Technology is a South Korean private company that operates as research institute.

Inspire Pharmaceuticals, Inc. is a biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. The advanced compounds in the clinical pipeline are denufosol tetrasodium for cystic fibrosis and Prolacria for dry eye, both of which are in Phase III development, and AzaSite for blepharitis, which is in Phase II development.

ChemoCentryxis a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer. ChemoCentryx focuses on the discovery, development, and commercialization of orally-administered small molecule therapeutics that target chemokine receptors and related chemo-attractant receptors. The company's small molecule product candidates are designed to target a specific chemokine or chemo-attractant receptor, thereby blocking the inappropriate immune system cascade underlying a given disease.

Novartis International Pharmaceutical Ltd. manufactures and distributes pharmaceutical products. The company is headquartered in Ireland.

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Shanghai Baiyiyuan Biological Engineering Co., Ltd., established on 2011-11-18, Business scope includes biological,Technology development in the field of medical science and technology,technical consulting,technology transfer,Technical Services,Research and development of biological products,Medical device production(see license),Engaged in the production of wound healing biofilms,Medical device management,Cosmetic sales. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shenyang Mind Medical System Co., Ltd., established on 2020-06-02, Business scope includes general items:Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology),Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Sales of Class II Medical Devices,Sales of Class I Medical Devices,Production of Class I Medical Devices,Mechanical Parts,Parts sales,Mechanical Parts,Parts processing,housing lease,property management(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Guangzhou Baiji Gene Technology Co., Ltd., established on 2015-07-24, Business scope includes technical services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Development of Human Gene Diagnosis and Therapy Technology;Nursing facility services(Does not include medical services);Medical equipment rental;Human stem cell technology development and application;R&D and application of cell technology;Sales of hygiene products and single-use medical products;Sales of Class II Medical Devices;Sales of Class I Medical Devices;pharmaceutical production;Drug internet information service;Drug Wholesale;Production of hygiene products and single-use medical products;Drug retail;Class III medical device business;Technology Import and Export;Import and export;Drug import and export;

Insight Biotechnology Ltd. supplies life science tools designed to further understanding of physiology, cell biology and disease mechanisms. Its custom services include proteomics, antibody production, peptide synthesis, peptide library, protein production, organic synthesis, tissue procurement custom TMS, cDNA libraries, epigenetics and genscript. The company was founded on August 21, 1995 and is headquartered in London, the United Kingdom.

CBR, Inc., part of Dufry AG, is a company headquartered in Minneapolis, MN, that designs, develops, and operates airport specialty retail stores. On December 17, 2007 Autogrill SpA, now a subsidiary of Dufry AG acquired CBR, Inc. for $23 million.

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.